Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
20.24
+0.44 (2.22%)
At close: Sep 4, 2026, 4:00 PM EDT
20.50
+0.26 (1.28%)
After-hours: Sep 4, 2026, 7:30 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.24 billion as of September 4, 2026. Its market cap has decreased by -10.63% in one year.
Market Cap
1.24B
Enterprise Value
287.49M
1-Year Change
-10.63%
Ranking
Category
Stock Price
$20.24
ChartMarket Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.24B, an increase of 101.62%. That is a compound annual growth rate of 14.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 1.24B | 49.08% |
| Dec 31, 2025 | 830.04M | -73.11% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
| Jun 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ORIC Pharmaceuticals | 1.33B |
| Seaport Therapeutics | 1.33B |
| Immatics | 1.31B |
| MannKind | 1.31B |
| MoonLake Immunotherapeutics | 1.28B |
| Jade Biosciences | 1.27B |
| Corvus Pharmaceuticals | 1.21B |
| Monte Rosa Therapeutics | 1.18B |